KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to -$3.0 million.

  • Chemed's Deferred Taxes fell 182342.86% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.2 million, marking a year-over-year decrease of 78980.39%. This contributed to the annual value of -$4.1 million for FY2024, which is 4844.9% up from last year.
  • As of Q3 2025, Chemed's Deferred Taxes stood at -$3.0 million, which was down 182342.86% from $931000.0 recorded in Q2 2025.
  • Over the past 5 years, Chemed's Deferred Taxes peaked at $12.5 million during Q3 2022, and registered a low of -$14.2 million during Q1 2025.
  • Over the past 5 years, Chemed's median Deferred Taxes value was $175000.0 (recorded in 2024), while the average stood at -$589315.8.
  • In the last 5 years, Chemed's Deferred Taxes soared by 87772.95% in 2022 and then crashed by 182342.86% in 2025.
  • Over the past 5 years, Chemed's Deferred Taxes (Quarter) stood at $3.0 million in 2021, then surged by 49.24% to $4.4 million in 2022, then plummeted by 95.36% to $205000.0 in 2023, then plummeted by 1023.41% to -$1.9 million in 2024, then tumbled by 59.32% to -$3.0 million in 2025.
  • Its last three reported values are -$3.0 million in Q3 2025, $931000.0 for Q2 2025, and -$14.2 million during Q1 2025.